Locally advanced head and neck squamous cell carcinoma treatment efficacy and safety: a systematic review and network meta-analysis

Head and neck squamous cell carcinoma (HNSCC) accounts for approximately 3% of new cancer cases and 3% of all deaths worldwide. Most HNSCC patients are locally advanced (LA) at diagnosis. The combination of radiotherapy (RT), chemotherapy, targeted therapy, and immunotherapy are the primary LA-HNSCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huanhuan, Zheng, Zhuangzhuang, Zhang, Yangyu, Bian, Chenbin, Bao, Jindian, Xin, Ying, Jiang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546034/
https://www.ncbi.nlm.nih.gov/pubmed/37795033
http://dx.doi.org/10.3389/fphar.2023.1269863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546034/
https://www.ncbi.nlm.nih.gov/pubmed/37795033
http://dx.doi.org/10.3389/fphar.2023.1269863

Ejemplares similares